Search Results - "Bouillet, Benjamin"

Refine Results
  1. 1
  2. 2

    Role of apolipoprotein C1 in lipoprotein metabolism, atherosclerosis and diabetes: a systematic review by Rouland, Alexia, Masson, David, Lagrost, Laurent, Vergès, Bruno, Gautier, Thomas, Bouillet, Benjamin

    Published in Cardiovascular diabetology (05-12-2022)
    “…Apolipoprotein C1 (apoC1) is a small size apolipoprotein whose exact role is not totally clarified but which seems to modulate significantly the metabolism of…”
    Get full text
    Journal Article
  3. 3

    Expert opinion on immunotherapy induced diabetes by Smati, Sarra, Buffier, Perrine, Bouillet, Benjamin, Archambeaud, Françoise, Vergès, Bruno, Cariou, Bertrand

    Published in Annales d'endocrinologie (01-10-2018)
    “…Immunotherapy often incurs side-effects, mainly involving the skin, digestive tract and endocrine system. The most frequent endocrine side-effects involve the…”
    Get full text
    Journal Article
  4. 4

    HDL functionality in type 1 diabetes: enhancement of cholesterol efflux capacity in relationship with decreased HDL carbamylation after improvement of glycemic control by Denimal, Damien, Monier, Serge, Simoneau, Isabelle, Duvillard, Laurence, Vergès, Bruno, Bouillet, Benjamin

    Published in Cardiovascular diabetology (12-08-2022)
    “…Abstract Background Reduced cholesterol efflux capacity (CEC) of HDLs is likely to increase cardiovascular risk in type 1 diabetes (T1D). We aimed to assess…”
    Get full text
    Journal Article
  5. 5

    High-Density Lipoprotein Alterations in Type 2 Diabetes and Obesity by Denimal, Damien, Monier, Serge, Bouillet, Benjamin, Vergès, Bruno, Duvillard, Laurence

    Published in Metabolites (01-02-2023)
    “…Alterations affecting high-density lipoproteins (HDLs) are one of the various abnormalities observed in dyslipidemia in type 2 diabetes mellitus (T2DM) and…”
    Get full text
    Journal Article
  6. 6

    Significant abnormalities of the HDL phosphosphingolipidome in type 1 diabetes despite normal HDL cholesterol concentration by Denimal, Damien, Pais de Barros, Jean-Paul, Petit, Jean-Michel, Bouillet, Benjamin, Vergès, Bruno, Duvillard, Laurence

    Published in Atherosclerosis (01-08-2015)
    “…Abstract Objective Phospholipids and sphingolipids are major components of HDL. They play a critical role in HDL functionality and protective effects against…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Plasma ceramides are associated with MRI-based liver fat content but not with noninvasive scores of liver fibrosis in patients with type 2 diabetes by Denimal, Damien, Béland-Bonenfant, Sarah, Pais-de-Barros, Jean-Paul, Rouland, Alexia, Bouillet, Benjamin, Duvillard, Laurence, Vergès, Bruno, Petit, Jean-Michel

    Published in Cardiovascular diabetology (08-11-2023)
    “…Abstract Background There is growing evidence that ceramides play a significant role in the onset and progression of non-alcoholic fatty liver disease (NAFLD),…”
    Get full text
    Journal Article
  9. 9

    Liraglutide reduces plasma dihydroceramide levels in patients with type 2 diabetes by Denimal, Damien, Bergas, Victoria, Pais-de-Barros, Jean-Paul, Simoneau, Isabelle, Demizieux, Laurent, Passilly-Degrace, Patricia, Bouillet, Benjamin, Petit, Jean-Michel, Rouland, Alexia, Bataille, Amandine, Duvillard, Laurence, Vergès, Bruno

    Published in Cardiovascular diabetology (04-05-2023)
    “…Emerging evidence supports that dihydroceramides (DhCer) and ceramides (Cer) contribute to the pathophysiology of insulin resistance and liver steatosis, and…”
    Get full text
    Journal Article
  10. 10

    The Endogenous Inhibitor of CETP, apoC1, Remains Ineffective In Vivo after Correction of Hyperglycemia in People with Type 1 Diabetes by Rouland, Alexia, Gautier, Thomas, Denimal, Damien, Duvillard, Laurence, Simoneau, Isabelle, Rageot, David, Vergès, Bruno, Bouillet, Benjamin

    Published in Metabolites (07-09-2024)
    “…ApolipoproteinC1 (apoC1) is the main physiological inhibitor of the cholesterol ester transfer protein (CETP). Increased CETP activity is associated with…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Case Report: Giant insulinoma, a very rare tumor causing hypoglycemia by Tarris, Georges, Rouland, Alexia, Guillen, Kévin, Loffroy, Romaric, Lariotte, Anne-Cécile, Rat, Patrick, Bouillet, Benjamin, Andrianiaina, Haingo, Petit, Jean-Michel, Martin, Laurent

    Published in Frontiers in endocrinology (Lausanne) (10-05-2023)
    “…Insulinomas, with an incidence of 4 cases per million individuals per year, remain amongst the most frequent functional neuroendocrine tumors. The usual…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Constitutive inhibition of plasma CETP by apolipoprotein C1 is blunted in dyslipidemic patients with coronary artery disease[S] by Pillois, Xavier, Gautier, Thomas, Bouillet, Benjamin, Pais de Barros, Jean-Paul, Jeannin, Aline, Vergès, Bruno, Bonnet, Jacques, Lagrost, Laurent

    Published in Journal of lipid research (01-06-2012)
    “…Plasma cholesteryl ester transfer protein (CETP) promotes the cholesterol enrichment of apoB-containing lipoproteins (VLDL and LDL) at the expense of HDL…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Primary hyperparathyroidism: From diagnosis to treatment by Carpentier, Laure, Bouillet, Benjamin

    Published in La revue de medecine interne (07-09-2024)
    “…Primary hyperparathyroidism (PHPT) is the leading cause of hypercalcemia. It is secondary to hypersecretion of parathyroid hormone (PTH) by the parathyroid…”
    Get full text
    Journal Article
  19. 19
  20. 20